Cargando…
Opana(®) ER induced thrombotic thrombocytopenic purpura
We present the case of a patient who developed thrombotic thrombocytopenic purpura (TTP) following intravenous injection of Opana(®) ER. TTP reemerged after three months of abstinence with Opana misuse. This case report brings awareness to the possibility of developing TTP in those who misuse Opana,...
Autores principales: | Kotbi, Nabil, Han, Bernadine, Cheng, Duncan, Odom, Anna E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425330/ https://www.ncbi.nlm.nih.gov/pubmed/25995651 http://dx.doi.org/10.2147/IMCRJ.S65655 |
Ejemplares similares
-
Opana-induced thrombotic microangiopathy masquerading as thrombotic thrombocytopenic purpura
por: Ban, Byung H., et al.
Publicado: (2017) -
Thrombotic Thrombocytopenic Purpura (TTP)–Like Illness Associated with Intravenous Opana ER Abuse — Tennessee, 2012
por: Marder, Ellyn, et al.
Publicado: (2013) -
Thrombotic Microangiopathy Secondary to Intravenous Abuse of Opana® ER
por: Thakur, Kamia, et al.
Publicado: (2017) -
Opana ER (Oxymorphone)–Induced Thrombotic Microangiopathy: An Atypical Presentation in a Patient With Hepatitis C
por: Mehmood, Hassan, et al.
Publicado: (2018) -
Bilateral exudative retinal detachments due to thrombotic microangiopathy associated with intravenous abuse of Opana ER
por: Aseem, Fazila, et al.
Publicado: (2018)